PremiumCompany AnnouncementsSurgery Partners Reports Q1 Revenue Growth and Reaffirms 2025 Outlook Surgery Partners Inc. Reports Strong Growth Amid Challenges Positive Outlook for Surgery Partners: Buy Rating Affirmed Amid Margin Expansion and Strategic Growth PremiumThe FlySurgery Partners price target lowered to $28 from $32 at TD Cowen Surgery Partners: Strong Growth and Strategic Positioning Drive Buy Rating Surgery Partners: Strong Financial Performance and Strategic Growth Drive Buy Rating PremiumCompany AnnouncementsSurgery Partners Inc. Reports Record Growth in Earnings Call Trump announces crypto reserve, Kroger CEO resigns: Morning Buzz Surgery Partners see FY25 revenue $3.3B-$3.45B, consensus $3.39B